Literature DB >> 22037646

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.

Kristin M Nieman1, Hilary A Kenny, Carla V Penicka, Andras Ladanyi, Rebecca Buell-Gutbrod, Marion R Zillhardt, Iris L Romero, Mark S Carey, Gordon B Mills, Gökhan S Hotamisligil, S Diane Yamada, Marcus E Peter, Katja Gwin, Ernst Lengyel.   

Abstract

Intra-abdominal tumors, such as ovarian cancer, have a clear predilection for metastasis to the omentum, an organ primarily composed of adipocytes. Currently, it is unclear why tumor cells preferentially home to and proliferate in the omentum, yet omental metastases typically represent the largest tumor in the abdominal cavities of women with ovarian cancer. We show here that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities. Adipocyte-ovarian cancer cell coculture led to the direct transfer of lipids from adipocytes to ovarian cancer cells and promoted in vitro and in vivo tumor growth. Furthermore, coculture induced lipolysis in adipocytes and β-oxidation in cancer cells, suggesting adipocytes act as an energy source for the cancer cells. A protein array identified upregulation of fatty acid-binding protein 4 (FABP4, also known as aP2) in omental metastases as compared to primary ovarian tumors, and FABP4 expression was detected in ovarian cancer cells at the adipocyte-tumor cell interface. FABP4 deficiency substantially impaired metastatic tumor growth in mice, indicating that FABP4 has a key role in ovarian cancer metastasis. These data indicate adipocytes provide fatty acids for rapid tumor growth, identifying lipid metabolism and transport as new targets for the treatment of cancers where adipocytes are a major component of the microenvironment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037646      PMCID: PMC4157349          DOI: 10.1038/nm.2492

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  36 in total

Review 1.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.

Authors:  Y Liu
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-05-09       Impact factor: 5.554

2.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

Authors:  Kathrin Zaugg; Yi Yao; Patrick T Reilly; Karuppiah Kannan; Reza Kiarash; Jacqueline Mason; Ping Huang; Suzanne K Sawyer; Benjamin Fuerth; Brandon Faubert; Tuula Kalliomäki; Andrew Elia; Xunyi Luo; Vincent Nadeem; David Bungard; Sireesha Yalavarthi; Joseph D Growney; Andrew Wakeham; Yasmin Moolani; Jennifer Silvester; Annick You Ten; Walbert Bakker; Katsuya Tsuchihara; Shelley L Berger; Richard P Hill; Russell G Jones; Ming Tsao; Murray O Robinson; Craig B Thompson; Guohua Pan; Tak W Mak
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

3.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

4.  Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells.

Authors:  Lisa S Pike; Amy L Smift; Nicole J Croteau; David A Ferrick; Min Wu
Journal:  Biochim Biophys Acta       Date:  2011-06

5.  Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

Authors:  K T Uysal; L Scheja; S M Wiesbrock; S Bonner-Weir; G S Hotamisligil
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

6.  Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

Authors:  G S Hotamisligil; R S Johnson; R J Distel; R Ellis; V E Papaioannou; B M Spiegelman
Journal:  Science       Date:  1996-11-22       Impact factor: 47.728

Review 7.  Precursors to pelvic serous carcinoma and their clinical implications.

Authors:  Ann K Folkins; Elke A Jarboe; Michael H Roh; Christopher P Crum
Journal:  Gynecol Oncol       Date:  2009-02-23       Impact factor: 5.482

8.  Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.

Authors:  Coralie Sengenes; Anne Bouloumie; Hans Hauner; Michel Berlan; Rudi Busse; Max Lafontan; Jean Galitzky
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

9.  Thyroid-stimulating hormone stimulates lipolysis in adipocytes in culture and raises serum free fatty acid levels in vivo.

Authors:  Annemarie Gagnon; Tayze T Antunes; Tapraya Ly; Patama Pongsuwan; Claire Gavin; Heather A Lochnan; Alexander Sorisky
Journal:  Metabolism       Date:  2009-10-20       Impact factor: 8.694

Review 10.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

View more
  833 in total

1.  Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Authors:  Kaitlin C Fogg; Carine M Renner; Hannah Christian; Alyssa Walker; Leilani Marty-Santos; Aisha Khan; Will R Olson; Carl Parent; Andrea O'Shea; Deneen M Wellik; Paul S Weisman; Pamela K Kreeger
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

2.  Gynecological cancer: Home is where the fat is.

Authors:  M Teresa Villanueva
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

3.  Lipid Metabolism in Tumor-Infiltrating T Cells.

Authors:  Shangwen He; Ting Cai; Juanjuan Yuan; Xiaojun Zheng; Wei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models.

Authors:  Robert Clark; Venkatesh Krishnan; Michael Schoof; Irving Rodriguez; Betty Theriault; Marina Chekmareva; Carrie Rinker-Schaeffer
Journal:  Am J Pathol       Date:  2013-08       Impact factor: 4.307

5.  Sucrose Non-Fermenting Related Kinase Expression in Ovarian Cancer and Correlation with Clinical Features.

Authors:  Elizabeth E Hopp; Stephanie M Cossette; Suresh N Kumar; Daniel Eastwood; Ramani Ramchandran; Erin Bishop
Journal:  Cancer Invest       Date:  2017-07-19       Impact factor: 2.176

Review 6.  Clinical implications of bone marrow adiposity.

Authors:  A G Veldhuis-Vlug; C J Rosen
Journal:  J Intern Med       Date:  2018-01-15       Impact factor: 8.989

Review 7.  Nitric Oxide: The Forgotten Child of Tumor Metabolism.

Authors:  Bahar Salimian Rizi; Abhinav Achreja; Deepak Nagrath
Journal:  Trends Cancer       Date:  2017-08-18

8.  Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer.

Authors:  Masakazu Sato; Kei Kawana; Katsuyuki Adachi; Asaha Fujimoto; Mitsuyo Yoshida; Hiroe Nakamura; Haruka Nishida; Tomoko Inoue; Ayumi Taguchi; Juri Ogishima; Satoko Eguchi; Aki Yamashita; Kensuke Tomio; Atsushi Komatsu; Osamu Wada-Hiraike; Katsutoshi Oda; Takeshi Nagamatsu; Yutaka Osuga; Tomoyuki Fujii
Journal:  Oncol Lett       Date:  2017-11-09       Impact factor: 2.967

9.  Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion.

Authors:  Jessica Tang; Nicholas Pulliam; Ali Özeş; Aaron Buechlein; Ning Ding; Harold Keer; Doug Rusch; Heather O'Hagan; M Sharon Stack; Kenneth P Nephew
Journal:  Mol Cancer Res       Date:  2018-05-14       Impact factor: 5.852

10.  Epidermal FABP Prevents Chemical-Induced Skin Tumorigenesis by Regulation of TPA-Induced IFN/p53/SOX2 Pathway in Keratinocytes.

Authors:  Yuwen Zhang; Jiaqing Hao; Jun Zeng; Qiang Li; Enyu Rao; Yanwen Sun; Lianliang Liu; Anita Mandal; V Douglas Landers; Rebecca J Morris; Margot P Cleary; Jill Suttles; Bing Li
Journal:  J Invest Dermatol       Date:  2018-03-17       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.